106 related articles for article (PubMed ID: 2783546)
1. [Immune parameters of peripheral blood in chemoembolization with microencapsulated anticancer drugs].
Sato K; Abe R; Moriyama M; Kato T; Tsuchida S
Gan To Kagaku Ryoho; 1989 Jan; 16(1):73-7. PubMed ID: 2783546
[TBL] [Abstract][Full Text] [Related]
2. [Arterial chemoembolization using microencapsulated anticancer drugs].
Sato K; Kato T
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1105-10. PubMed ID: 1693486
[TBL] [Abstract][Full Text] [Related]
3. An assessment of lymphocytic population in peripheral blood of patients with renal cell carcinoma before and after embolization.
Osada J; Pietruczuk M; Dabrowska M; Kordecki K; Janica J; Walecki J
Rocz Akad Med Bialymst; 2000; 45():228-39. PubMed ID: 11712434
[TBL] [Abstract][Full Text] [Related]
4. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of natural killer cell activity after arterial embolization of renal carcinomas.
Bakke A; Göthlin JH; Haukaas SA; Kalland T
Cancer Res; 1982 Sep; 42(9):3880-3. PubMed ID: 7105048
[TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial chemotherapy in urological cancer].
Mitsumori K; Sato K; Kato T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):197-203. PubMed ID: 11865624
[TBL] [Abstract][Full Text] [Related]
7. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
8. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte therapy of renal cell carcinoma.
Dillman RO
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1041-51. PubMed ID: 16336095
[TBL] [Abstract][Full Text] [Related]
10. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
[TBL] [Abstract][Full Text] [Related]
11. [Arterial infusion of microencapsulated mitomycin C for the treatment of locally recurrent carcinoma of the pelvic cavity].
Nemoto R; Kato T; Mori H; Chiba R; Shindo M; Kato H
Gan To Kagaku Ryoho; 1982 Apr; 9(4):646-51. PubMed ID: 6820903
[TBL] [Abstract][Full Text] [Related]
12. The role of embolization/chemoembolization in the treatment of renal cell carcinoma.
Kato T; Sato K; Abe R; Moriyama M
Prog Clin Biol Res; 1989; 303():697-705. PubMed ID: 2506558
[No Abstract] [Full Text] [Related]
13. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
[No Abstract] [Full Text] [Related]
14. [The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas].
Fukasawa K
Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):239-45. PubMed ID: 3226000
[No Abstract] [Full Text] [Related]
15. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
[TBL] [Abstract][Full Text] [Related]
16. [Chemoembolization using microencapsulated anticancer drugs].
Sato K; Kato T
Nihon Rinsho; 1989 Jun; 47(6):1379-83. PubMed ID: 2770000
[No Abstract] [Full Text] [Related]
17. [Immunological effect of recombinant interferon-gamma in renal cell carcinoma].
Kawata N; Ono M; Endo M; Ichinose T; Hamada T; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1993 Jun; 39(6):511-5. PubMed ID: 8337976
[TBL] [Abstract][Full Text] [Related]
18. [Combined treatment of irradiation and 8 MHz radiofrequency hyperthermia with chemoembolization in advanced renal tumor].
Nakajima K; Hisazumi H; Tokunaga S; Nitta M; Nakashima T; Fuse H; Saito Y; Takashima T; Kojima A; Annen Y
Gan No Rinsho; 1987 Apr; 33(4):421-7. PubMed ID: 3106675
[TBL] [Abstract][Full Text] [Related]
19. Microencapsulated mitomycin C in transcatheter embolization of dog kidney.
Nemoto R; Kato T; Mori H; Harada M
Invest Urol; 1980 Jul; 18(1):69-73. PubMed ID: 7410016
[TBL] [Abstract][Full Text] [Related]
20. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
